Enveric Biosciences Inc. (NASDAQ: ENVB) reported its financial results for the third quarter of 2024 and provided a corporate update yesterday. Enveric said it made “important progress” in the development of EB-003, its lead neuroplastogenic molecule designed to treat depression, anxiety and addiction disorders without causing the hallucinogenic effects common to DMT and related analogs. According […]
The drugmaker’s Colombian licensing deals helped drive a sevenfold jump in South American revenue. Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) managed to lift its margins while posting flat revenue in the third quarter as summer sales slowed. Revenue reached C$6.3 million for the three months ended Sept. 30, a marginal 0.34% increase from C$6.25 million […]
Acreage Holdings Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) reported wider losses in the third quarter as the multi-state cannabis operator wrestles with competitive pressures ahead of its planned acquisition by Canopy USA. The New York-based company posted a net loss of $22.2 million for the quarter ending Sept. 30, versus a loss of $7.9 million […]
California-based Lowell Farms (CSE: LOWL) (OTCQX: LOWLF) this week reported a net loss of $3.6 million for the third quarter, down significantly year-over-year, but adding to its year-to-date losses, which now stand at $7.3 million. Revenue for the quarter hit $3.2 million, a year-over-year decrease of 48% from $6.2 million, with revenue for the first […]
Earlier this month, a stay was granted for the company’s limited receivership. California-based Gold Flora Corp. (CBOE: GRAM) (OTCQB: GRAM) this week reported a net loss of $18.8 million, bringing its losses for the year thus far to $56.5 million, a dramatic turnaround from a year ago, when the company reported net income of $22.9 […]
Vancouver-based C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) bucked state cannabis market trends with a 14% sequential revenue jump to $7.5 million in its fiscal second quarter, as its new south Reno location helped offset broader headwinds. The retail segment generated $7.1 million in the second quarter, up 10% from $6.4 million in the year-ago […]
The company still ended the quarter on a pile of cash to support its R&D efforts. Toronto-based Cybin Inc. (NYSE: CYBN) reported financials for its fiscal second quarter 2025 ending Sept. 30, with higher R&D costs from its clinical programs. The company also announced it has initiated a phase 3 program evaluating its psilocin-based CYB003 […]
The hemp extracts maker said its B2B sales fell during the quarter due to patchwork state laws around CBD. CV Sciences Inc. (OTCQB: CVSI) reported third-quarter revenue of $3.9 million, down 5% from the year-ago period, according to the company Thursday. The San Diego-based hemp extracts maker said the decline was mostly due to a […]
Colorado-based Charlotte’s Web Holdings (TSX: CWEB) (OTCQX: CWBHF) reported that its third-quarter revenue fell 11.9% since last year to $12.6 million, as the hemp extract maker deals with regulatory uncertainty and reduced retail shelf space. The CBD wellness company’s revenue for the quarter that ended Sept 30 was a slight miss on analysts’ expectations of […]
IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) announced its financial results today for the third quarter ending Sept. 30. IM Cannabis reported revenue increased 12% to C$13.9 million compared to C$12.4 million in the 2023 third quarter. The company attributed the increase to accelerated revenue growth in Germany, which reached C$4.3 million, and decreased net […]
